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Abstract
Cytochrome P450s are very large and diverse superfamily of hemoproteins found in all domains of life and diverse array of compounds can 
influence the relative concentrations and/or activities of P450s. Expression of P450s is modulated not only by exposure to various chemicals, but 
also by some pathophysiological conditions such as diabetes, hypertension and obesity. 
Six different Cytochrome P450 isoforms namely; 1A1, 2A1, 2E1, 2C11, 3A1, 4A1 were quantified by quantitative Real Time PCR to assess 
the relative expressions of CYPs mRNA in control and diabetic rat liver tissues. At the same time, effects of resveratrol (RSV) on these isoforms 
were evaluated. According to results, diabetes enhanced the CYP1A1, CYP2E1 and CYP3A1 gene expression and RSV reduced to these increments 
toward the control values. Furthermore, while CYP2C11 and CYP4A1 expressions were found to be reduced by diabetes, application of RSV 
decreased these isoforms’expressions further. Additionally, diabetes and RSV treatment did not alter the CYP2A1&2 expressions significantly.
As a result, expressions of cytochrome P450 were altered not only by diabetes but also by exposure to antioxidants such as resveratrol and 
levels of expressions of each isoforms are important factors determining the biological consequences of xenobiotics and antioxidant defense 
systems in diabetes. 
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INTRODUCTION
Free radicals are atoms or groups of atoms with an 
odd (unpaired) number of electrons and can be formed 
when oxygen interacts with certain molecules. Under 
normal conditions the body can easily handle free radicals 
but increased oxygen flux or decreased removal may 
ultimately results in oxidative stress. Factors such as site 
of production, the availability of transition metals, and 
the action of enzymes determine the fate of each radical 
species. The consequences of free radicals in biological 
systems are manifold and include damage to all cell 
constituents which are prone to oxidative attack.
Biological antioxidants are natural molecules which 
can prevent the uncontrolled formation of free radicals and 
activated oxygen species, or inhibit their reactions with 
biological structures. Resveratrol (RSV), a phytoalexin 
abundantly found in grapes and red wine exhibited a 
large spectrum of beneficial health effects including free 
radical scavenging, cardioprotective [1], antiproliferative 
[2] and neuroprotective [3] properties. Plants produce 
RSV and other stilbenes in response to stress, injury, 
fungal infection, or ultraviolet (UV) radiation. RSV 
suppresses the expression of various isoforms of CYP 
under pathological conditions, which suggests its role in 
reduction of CYP-mediated ROS generation and thereby 
cellular toxicity [4-7]. 
Diabetes mellitus is a common disease characterized 
by the disordered metabolism and abnormally high blood 
glucose levels (hyperglycemia) resulting from insufficient 
levels of insulin or its action on cells.  Elevated blood 
glucose levels cause free radicals to be produced 
via glucose autoxidation [8], non-enzymatic protein 
glycation [9], increased influx toward polyol pathway 
[10], activation of protein kinase C and increased flux 
through hexosamine pathway [11]. Hyperglycemia may 
initiate and promote progression of diabetic disease and 
lead to insulin resistance and hyperinsulinemia [12], 
altered fatty acid metabolism, hypertension, ketoacidosis, 
osmotic effects, vasoactive hormones and dysfunction in 
sympathetic regulation of glucose and fat metabolism 
[13]. Furthermore, several theories explain the most 
adverse effects of hyperglycemia by oxidative stress 
responsible for tissue damage.
The cytochrome P450 (CYP) is the superfamily of 
hemoproteins that mediate the biotransformation of 
endogenous and exogenous compounds.  Microsomal 
P450 catalyses the oxidative metabolism of a wide variety 
of lipophilic compounds such as drugs and carcinogens 
as well as endogenous steroids and fatty acids [14]. 
Foreign chemicals or drugs called xenobiotics especially 
lipophilic drugs are metabolized by Cytochrome P450s. 
The metabolism of these compounds takes place in 
two phases.  Phase I is chemical modification to add a 
functional group that can be used to attach a conjugate. 
The conjugate makes the modified compound more 
water soluble so it can be excreted in the urine.  Many 
P450s add a hydroxyl group in a Phase I step of drug 
metabolism.  The hydroxyl then serves as the site for 
further modifications in Phase 2 drug metabolism. 
The P450 proteins are categorized into families and 
subfamilies by their sequence similarities.  Sequences 
that are greater than 40% identical at the amino acid 
level belong to the same family.  Sequences that are 
greater than 55% identical are in the same subfamily. 
The P450-dependent metabolism of xenobiotics and 
drugs is primarily catalyzed by enzymes of the CYP1, 
CYP2, CYP3 and CYP4 families. The CYP1 families 
of P450s metabolize polyaromatic hydrocarbons 
(N-hydroxylation) and aromatic and heterocyclic amines 
(N-oxidation) and catalyze several reactions associated 
with carcinogen activation [15].
 CYP2 families are involved in drug and steroid 
metabolism. The most abundant form is the ethanol 
inducible CYP2E enzymes. CYP2B is inducible by 
barbiturates in rodents and CYP2C enzymes are the 
steroid hydroxylases. CYP2E1 is known to metabolize 
endogenous compounds such as fatty acids, lipid 
hydroperoxides, and ketone bodies into aldehyde and 
many xenobiotics and carcinogens into nucleophilic 
reactive species. Diabetes, fasting, and long-term alcohol 
consumption all result in altered nutritional status and 
metabolism (increased ketone body, glucose, and fatty 
acid levels) as well as altered hormone (insulin, glucagon, 
and growth hormone) secretion and so affect CYP2E 
family. 
CYP3 family is involved in drug metabolism and 
the CYP3A subfamily is one of the most important 
drug metabolizing families in humans [16]. CYP3A 
includes four genes, CYP3A4, CYP3A5, CYP3A7, and 
the recently identified CYP3A4. CYP3A4 is the most 
abundantly expressed P450 in human liver [17] and the 
color of perfused liver is due to this protein.  CYP3A4 is 
known to metabolize more than 120 different drugs.  
CYP4 families are involved in arachidonic acid or 
fatty acid metabolism. This family ω-hydroxylate the 
terminal carbon of fatty acids and subfamily members 
of this family show a preference in the metabolism of 
short (C7-C10)-CYP4B, medium (C10-C16)-CYP4A, 
and long (C16-C26)-CYP4F, saturated, unsaturated and 
branched chain fatty acids. 
This study concentrated on the regulation of the 
hepatic drug-metabolizing CYP genes in diabetes and 
showed the effects of intraperitonally administered 
antioxidant; resveratrol on some of the cytochrome P450 
gene expression in diabetic rat liver tissues. Six different 
Cytochrome P450 isoforms namely 1A1, 2A1, 2E1, 2C11, 
3A1, 4A1 were quantified with the help of quantitative 
Real Time PCR using SYBR Green I chemistry to assess 
the expressions of six different CYP genes as compared 
to internal standard β-Actin. 
MATERIALS AND METHODS
Male Wistar rats were randomly divided into three 
groups at the start of the experiment. In two groups 
diabetes was induced by single intraperitonal injection 
of Streptozotocin  (50 mg/kg body weight) dissolved 
in 0.05M citrate buffer (pH 4.5) and blood glucose 
concentrations were checked by Accu-check-go blood 
glucose analyzer (Roche) and animals having blood 
glucose concentration higher than 200mg/dl was 
considered as diabetics. After one week of diabetes, 
administration of antioxidants (50mg/kg body weight/
day) was started and the experimental groups comprised 
the control group (n=9), untreated diabetic group (n=9), 
diabetic groups supplemented with trans-resveratrol 
(D+R) (n=7). All experiments were carried out with the 
approval of ethical committee. The procedures involving 
animals and their care are conformed to the institutional 
guidelines [18]. At the end of the four week growing 
period, rats were decapitated and livers were removed 
and quickly frozen in liquid nitrogen and kept -85oC for 
subsequent biochemical analysis.
Total RNAs were isolated from the liver tissues by 
guanidine isothiocyanide method [19]. This method 
is based on differential extraction of RNAs by organic 
solvents. Proteins are denaturated by strong denaturating 
agent, Guanidine isothocyanide, and DNAs are selectively 
fractionated from RNAs by phenol at acidic pH. In order 
to decrease the possibility of RNA degradation during 
the procedure, all glassware and plastics were treated by 
0.1% DEPC (Diethyl Pyrocarbonate) solution overnight 
and then autoclaved and dried in oven which converts 
DEPC into CO2 and ethanol. Furthermore, all solutions 
were DEPC treated or prepared by 0.1% DEPC treated 
water to eliminate the RNAse activities. 
Immediately after removal from the animal, about 
500 mg liver tissue were minced on ice and homogenized 
(at room temperature) with 5 ml of solution D (4M 
Guanidine Isothiocyanide, 25mM Sodium Citrate pH:7.0, 
0.5% Sarcosyl, 0.1 M 2-mercaptoethanol) in a glass-
teflon homogenizer and subsequently transferred into 
pyrogen free 15ml polypropylene tube. Sequentially, 0.5 
ml of 2M sodium acetate (pH 4.0), 5 ml of phenol (water 
saturated, acidic pH) 1 ml of chloroform-isoamyl alcohol 
mixture (49:1) were added to the homogenate, with 
thorough mixing by inversion after the addition of each 
reagent. The final suspension were shaken vigorously for 
10 s and cooled on ice for 15 min. Then, samples were 
centrifuged at 10.000g for 20 min at 4°C and after that, 
RNA was present in the aqueous phase whereas DNA 
and proteins were present in the interphase and phenol 
phase, respectively. Five hundred microliter of aqueous 
phase was transferred to a fresh DNAse RNAse free 
eppendorf tube, mixed with 1 ml of isopropanol, and then 
placed at -20°C for at least 30 min to precipitate RNA. 
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Sedimentation at 10.000g for 20 min was again performed 
and the resulting RNA pellet was redissolved in 0.3 ml 
of solution D, which is re-precipitated with 1 volume 
of isopropanol at -20°C for 30 min. After centrifugation 
at 10.000g for 10 min at 4°C, the RNA pellet was 
resuspended and washed with 75% ethanol, sedimented 
by centrifugation, dried in oven (60-65oC, 15 min), 
and dissolved in 50µl DEPC treated water or deionized 
formamide at 65oC for 10min. Formamide provides a 
chemically stable environment that also protects RNA 
against degradation by RNAes. Purified, salt-free RNA 
dissolves quickly in formamide up to a concentration of 
4 mg/ml. At such concentrations, samples of the RNA 
can be analyzed directly by gel electrophoresis and RT-
PCR, saving time and avoiding potential degradation. If 
necessary, RNA can be recovered from formamide by 
precipitation with 4 volumes of ethanol as described by 
Chomczynski [20].
After isolation of total RNA, their integrities were 
checked by formaldehyde agarose gel electrophoresis 
and RNA concentrations and protein contamination were 
determined by spectrophotometry [21]. According to 
this, RNAs were diluted hundred times with TE buffer 
(10mM Tris, 1mM EDTA pH.8.0) in a quartz cuvette and 
absorbance of the solution was measured at 260 and 280 
nm using TE buffer as blank. The purity of the isolated 
RNA was determined by taking the ratio of A260 and 
A280 readings. 40µg/ml solution of single stranded RNA 
gives absorbance of 1.000 and by using this quotation, 
we calculated the concentration of the RNA in our sample 
as follows: RNA concentration (µg/ml) = (OD 260) x 
(dilution factor) x (40 µg RNA/µl)
  One microgram of total RNA was reverse transcribed 
into the cDNA by using M-MuLV Reverse transcriptase 
(MBI Fermentas, USA). To the reverse transcription 
reaction, 1μL oligo(dT)15 primer was added to 1μg 
total RNA. Then, the volume was completed to 12μL 
with DEPC-treated water. Afterwards, the mixture was 
gently mixed and incubated 5 min at 70oC and chilled 
on ice. Then 4μL of 5X M-MuLV reaction buffer and 
1μL of RiboLockTM (20u/ μL) (MBI Fermentas, USA) 
was added. After addition of 2μL 10 mM dNTP mix, 
tubes were incubated at 37oC for 5 min. Finally, 1μL 
of M-MuLV RT (200u/μL) is added and reaction was 
carried out at 42oC for 1 hour and stopped at 70oC for 
10 min with denaturation of reverse transcriptase. Finally, 
cDNA mixture was chilled on ice and stored at ambient 
temperature until subsequent PCR reactions. 
One microliter of cDNA mixture (1:10 diluted) was 
amplified in a 10μL of PCR mixture containing 5μL 
SYBR Green Mastermix (Roche FastStart Universal 
SYBR Green Master Mix with Rox) (2X) and 2μL forward 
and 2μL reverse primer (2mM each). Different primer 
sets were used to amplify the internal standard (β-Actin 
gene) and CYP genes (Table 1). The Real Time PCR 
program was set for initial denaturation at 95°C for 15 
minutes, denaturation at 94°C for 30 seconds, annealing 
at 58°C for 30 seconds and extension at 72°C for 30 
seconds. The cycle from denaturation to extension was 
repeated 40 times and at the end of each extension step 
green fluorescence was measured to follow the reaction 
chemistry on time in each cycle. Melt curve analysis was 
performed at the end of each run by rising the temperature 
from 50°C-99°C with the measurement of decrease in total 
flouresence which is used to determine the specificity of 
the final products. By taking the negative first derivative 
(-dF/dT) of the melting curve, the melting temperature 
of dsDNA can be easily visualized and compared, 
simplifying the specificity of final product. Although little 
or no primer-dimer formation was detected under normal 
PCR conditions (figure 1), the real-time thermal cycler 
(Rotor-gene 6000 Real-time rotary analyzer, Corbett Life 
Sciences, Sydney, Australia) was programmed to take 
fluorescence readings after each cycle at a temperature 
several degrees lower than the melting temperature of 
the amplicon. This step was taken to avoid or minimize 
any potential contribution of primer-dimers to the overall 
fluorescence signal. All PCR reactions were performed in 
duplicates and negative control samples were processed 
in the same manner, except that the template was omitted. 
Calibration curve was constructed by plotting the cross 
point (Ct) against serially diluted control cDNAs. The 
Ct is the cycle number at which the fluorescence signal 
is greater than a defined threshold, one in which all the 
reactions are in the logarithmic phase of amplification.
Also specification of the final product of each run 
was clarified by simple PCR amplification and agarose 
gel electrophoresis. To do this, 1 µl of cDNA mixture 
was amplified by conventional PCR in which initial 
denaturation at 94°C for 3 min, denaturation at 94°C 
for 30 sec, annealing at 58°C, extension at 72°C for 45 
sec (30 cycle) and final extension at 72°C for 5 min was 
carried out by using Eppendorf gradient type mastercycler 
(Eppendorf, Germany). 
After the reaction and agarose gel electrophoresis on 
1.2% agarose gels, specific PCR products indicating the 
specificity of the reactions were visualized as in figure 1. 
Statistical analysis
Data were expressed as mean  standard error of mean 
(SEM) and differences in measured parameters between 
control, diabetic and resveratrol supplemented animals 
were assessed by two tailed Student T-test with the help 
of MINITAB 12.1 statistics software. The relationships 
between oxidative parameters characterizing diabetic and 
control rat liver status were analyzed and a probability 
of 0.05 and 0.005 was set as the level of statistical 
significance. 
RESULTS
CYP1A1 also known as aryl hydrocarbon hydroxylase 
(AHH) is involved in the metabolic activation of aromatic 
hydrocarbons, such as benzopyrene, by transforming it to 
an epoxide. The expression of the CYP1A1 is regulated 
by the aryl hydrocarbon receptor, a ligand activated 
transcription factor [23]. As seen from the figure 2, diabetes 
enhanced the CYP1A1 gene expression significantly 
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around tenfold and administration of resveratrol did not 
change the diabetic CYP1A1 expression significantly.
CYP2A enzymes metabolize numerous xenobiotic 
compounds, such as coumarin, aflatoxin B1, nicotine, 
cotinine, acetaminophen, and 2,6-dichlorobenzonitrile, 
as well as endogenous compounds, including 
testosterone, progesterone, and other steroid hormones 
and the CYP2A1 and CYP2A2 genes code for hepatic 
steroid hydroxylases [24]. As seen in figure 2, in non-
treated diabetics and resveratrol administered diabetic 
rats, CYP2A1&2 gene expressions were not statistically 
different from the control expressions. 
The product of CYP2E1 metabolizes both endogenous 
substrates, such as ethanol, acetone, and acetaldehyde, as 
well as exogenous substrates including benzene, carbon 
tetrachloride, ethylene glycol, and nitrosamines. Due to 
its many substrates, this enzyme is involved in various 
processes such as gluconeogenesis, hepatic cirrhosis, 
diabetes, and cancer [25,26]. According to our results, 
diabetes causes an increment in the expression of 
CYP2E1 while RSV was too efficient for the lessening of 
CYP2E1 expression, which was found to be statistically 
significant.  
Gene expression of CYP2C11 enzyme, which is a male 
specific steroid 16α- and 2α-hydroxylase, was reduced 
in diabetic animals significantly. LA administration 
enhanced the expression of this enzyme in both control 
and diabetic animals and this increment were found to 
be significant. Resveratrol did not alter the CYP2C11 
expression in diabetic animals (Figure 1). 
 The CYP3A subfamily is involved in the metabolism 
of steroids and numerous xenobiotics and it is the most 
abundant human hepatic and intestinal CYP which 
is elevated in response to many xenobiotics by both 
transcriptional and post-transcriptional mechanisms [27]. 
According to our results, it has been found that diabetes 
increased the gene expression of CYP3A1. Resveratrol, 
which is a phytoalexins (antibiotics produced by plants 
that are under attack), reduces the CYP3A1 mRNA 
expressions in diabetic animals.  
The product of hepatic CYP4A gene is functioning 
in the fatty acid and prostaglandin omega-hydroxylases. 
In diabetes, there was a severe reduction in CYP4A1 
mRNA expression. When antioxidant; RSV were given 
to the control rats, there was significant reduction in 
the CYP4A1 mRNA expression which was found to be 
statistically significant (p<0.05). 
DISCUSSION
Microsomal cytochrome P450-dependent mixed-
function oxidases (cytochrome P450) are terminal 
monoxygenases involved in the metabolism of a wide 
variety of structurally diverse compounds. They play a 
major role in the metabolism of both endogenous and 
exogenous substrates. Cytochrome P450 metabolism 
may have one of two outcomes: detoxification of the 
xenobiotics by metabolism and conjugation and its safe 
excretion; or production of metabolites which are toxic 
and may be mutagenic or carcinogenic [28]. In vivo 
animal studies have shown that isoforms of several of 
the families of cytochrome P450 are associated with 
xenobiotic metabolism, are highly inducible by chemical 
exposure and pathological conditions such as diabetes 
mellitus in animals [29,30]. In this study, our aim is to 
demonstrate the changes in the gene expressions of six 
different cytochrome P450 isoforms namely 1A1, 2A1&2, 
2E1, 2C11, 3A1 and 4A1. In the literature, there is various 
studies in which alloxan or streptozotocin (STZ) is used 
as a diabetogenic agent. They have generally agreed that 
hepatic microsomal levels of CYP1A2, 2A1, 2B1, 2C7, 
2E1, and CYP4A enzymes are increased 2-4 weeks after 
treatment of male rats, whereas CYP2A2, 2C11, and 
2C13 levels are decreased [31,32]. 
CYP1A1 also known as aryl hydrocarbon 
hydroxylase is involved in the metabolic activation of 
aromatic hydrocarbons by transforming it to an epoxide. 
It has been shown that expression of the CYP1A1 genes 
are regulated by the aryl hydrocarbon receptor which 
is a ligand activated transcription factor [23]. Diabetes 
enhanced the CYP1A1 gene expression significantly and 
this increment suggests that transcriptional induction 
is present in diabetes. Coleman [15] stated that 1A1 
family is a not a constitutive enzyme in the liver because 
an individual is not exposed to planar polyaromatic 
hydrocarbons. We proposed that in diabetes there might 
be excessive accumulation of inducers in the liver 
causing CYP1A1 to be overexpressed.  Administration of 
RSV reversed this increment by somehow lessening these 
inducers. Furthermore, phase I metabolizing enzymes 
are known to produce free radical byproducts [33] and 
repression of CYP1A1 gene expression demonstrate that 
RSV decreases the diabetes induced free radical toxicity. 
CYP2A enzymes metabolize numerous xenobiotic 
compounds, such as coumarin, aflatoxin B1, nicotine, 
cotinine, acetaminophen, and 2,6-dichlorobenzonitrile, as 
well as endogenous compounds, including testosterone, 
progesterone, and other steroid hormones and the 
CYP2A1 and CYP2A2 genes code for hepatic steroid 
hydroxylases [24] . We found that diabetes and antioxidant 
treatment did not alter the CYP2A1&2 expressions 
indicating that in diabetes, steroid metabolism were not 
affected too much. Considering CYP2E1, there was 
an elevation in CYP2E1 mRNA which is in agreement 
with various studies carried out previously [34,35]. 
Current literature about CYP2E1 in diabetes states that 
enzyme is regulated at transcriptional, translational or 
posttranslational mechanism. The induction of CYP2E1 
mRNA is not accompanied by an increase in CYP2E1 
gene transcription, rather than mRNA is selectively 
stabilized in diabetes due to lack on insulin action. Since, 
mRNA of CYP2E1 was found to be destabilized by insulin 
[36]. Thus, elevation of CYP2E1 mRNA levels in the 
diabetic state has been attributed to mRNA stabilization. 
Reduction of this induction by antioxidant treatment 
suggests some other mechanisms which also regulate 
the mRNA levels of CYP2E1. Effects of antioxidants 
on CYP2E1 expression may be mediated by the reduced 
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levels of circulating ketone bodies; which has a direct 
effect on CYP2E1 expression in diabetes since elevated 
expression of CYP2E1 in these pathophysiological states 
in rats has been attributed to elevated ketone body levels. 
Gene expression of CYP2C11 enzyme, which is 
a male specific steroid 16α- and 2α-hydroxylase, was 
reduced in diabetic animals. RSV did not modulate the 
expression in diabetic rats. Since CYP2C11 expression in 
male rats is exquisitely sensitive to the temporal pattern 
of plasma growth hormones (GH) and the greatly reduced 
expression of this enzyme in diabetic rats is thought to be 
due in large part to the reduced GH secretion in these 
animals [37]. Furthermore, it was found that CYP2C11 
expression is suppressed by glucagon in a cAMP 
dependent manner [38], and this effect is antagonized 
by insulin. This suggests a role of hypoinsulinemia 
and hyperglucagonemia in the diabetic suppression of 
CYP2C11. 
The CYP3A subfamily is involved in the metabolism 
of steroids and numerous xenobiotics and CYP3A is 
the most abundant human hepatic and intestinal CYP 
and is elevated in response to many xenobiotics by both 
transcriptional and post-transcriptional mechanisms [27]. 
Different laboratories have reported either decreased 
[37], or increased [39] CYP3A protein expression 
following STZ treatment but neither of them focuses the 
effect of RSV treatment. According to our results, it has 
been found that diabetes increased the gene expression of 
CYP3A1 but hepatic CYP4A1 which is important fatty 
acid and prostaglandin omega-hydroxylases was severely 
reduced in diabetes. This study demonstrated that RSV 
reduced the CYP3A1 and CYP4A1 mRNA expressions 
in diabetic animals confirming reductive activities caused 
by this antioxidant.
As a summary, hepatic cytochrome P450 (P450) 
enzyme gene expressions were profoundly altered in 
streptozotocin induced diabetes. Increased or decreased 
levels of hepatic P450 enzymes by diabetes causes 
potential and documented impairment of drug clearance 
and clinical drug toxicity and modulation of P450s by 
selective application of antioxidants may provide a 
protection. Since, levels of expression of each isoform 
are important factors determining the biological 
consequences of antioxidants. 
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Table 1: Primer sequences and expected product sizes for different Cytochrome P450 and internal standard β-Actin 
[22].
cDNA Forward primer sequence Reverse primer sequence RT-PCR product size
β-Actin 5′-CCTGCTTGCTGATC-
CACA
5′-CTGACCGAGCGT-
GGCTAC
505 bp
CYP1A1 5′-CTGGTTCTGGATAC-
CCAGCTG
5′-CCTAGGGTTGGTTAC-
CAGG
331 bp
CYP2A1&2A2 5′-CACAGGGCAGCTC-
TATGACA
5′-CAGACCCAGCAAA-
GAAGAGG
275 bp
CYP2E1 5′-CTCCTCGTCATATC-
CATCTG
5′-GCAGCCAATCA-
GAAATGTGG
473 bp
CYP2C11 5′-CTGCTGCTGCT-
GAAACACGTG
5′-GGATGACAGCGATAC-
TATCAC
248 bp
CYP3A1 5′-ATCCGATATGGAGAT-
CAC
5′-GAAGAAGTCCTT-
GCTTGC
579 bp
CYP4A1 5′-GGTGACAAAGAACTA-
CAGC
5′-AGAGGAGTCTTGAC-
CTGCCAG
344 bp
Table 2: Overall summary of CYP expressions with respect to internal standard; β-Actin in control, diabetic and 
resveratrol administered diabetic (D+RSV) rat liver tissues.
N CYP1A1 CYP2A1&2 CYP2E1 CYP2C11 CYP3A1 CYP4A1
Control 9 0,146±0,044 0,455±0,039 0,904±0,208 2,686±0,504 0,323±0,049 0,221±0,018
Diabetic 9 1,253±0,232 a 0,479±0,113 1,215±0,171 a 0,146±0,030 aa 0,793±0,193 a 0,090±0,023 aa
D+RSV 7 1,143±0,434 a 0,386±0,047 0,379±0,128 a,b 0,128±0,035 aa 0,269±0,056 b 0,030±0,009 b
a   Represents significance at P < 0,05 as compared with control groups
aa Represents significance at P < 0,005 as compared with control groups
b  Represents significance at P < 0,05 as compared with untreated diabetic groups
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Figure 2: Relative mRNA expressions of several CYP isoforms in control, diabetic and resveratrol administered 
diabetic liver tissues. Measurements were carried out by real time polymerase chain reaction and normalized in 
response to internal standard.
Figure 1: Products of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) amplifications of different CYP 
genes and internal standards from a control animal to show whether selected primer pairs amplify correct products 
without any sign of by products which is also confirmed by melt analysis in Real Time PCR reactions. Products 
were resolved by 1.2% agarose gel electrophoresis.
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